尽管收入出现小幅下滑,但BrightSpring健康服务升级为"强买入", 
BrightSpring Health Services upgraded to "Strong-Buy" despite slight earnings miss, driven by strong revenue growth and rising analyst confidence.
BrightSpring健康服务（BTSG）获得了Zacks Research的“强力买入”上调，多家公司上调了价格目标，理由是尽管第四季度财报略有偏低，但增长强劲。 BrightSpring Health Services (BTSG) received a "Strong-Buy" upgrade from Zacks Research and multiple firms raised price targets, citing strong growth despite a slight earnings miss in Q4. 该公司报告,EPS为0.33美元,收入增长29.3%,达到35.5亿美元,分析家预测,2026 EPS为0.59美元。 The company reported $0.33 EPS and a 29.3% revenue increase to $3.55 billion, with analysts projecting 2026 EPS of $0.59. 股价为41.96美元,市场上限为81.2亿美元,具有共识的“Buy”评级,目标为44.08美元。 The stock, trading at $41.96 with a market cap of $8.12 billion, has a consensus "Buy" rating and a target of $44.08. 机构所有权大幅上升,在分析师信心不断增强的情况下,公司P/E比率保持在47.68的高水平。 Institutional ownership rose significantly, and the company maintains a high P/E ratio of 47.68 amid growing analyst confidence.
